Literature DB >> 6733215

Effect of the chemical structure of N-(2-hydroxypropyl)methacrylamide copolymers on their ability to induce antibody formation in inbred strains of mice.

B Rihová, J Kopecek, K Ulbrich, M Pospisil, P Mancal.   

Abstract

The homopolymer of N-(2-hydroxypropyl)methacrylamide (HPMA) and copolymers of HPMA differing in oligopeptide side chains (-Gly-Gly-OH; -Acap-Phe-OH; -Acap-Leu-HMDA and -Gly-Phe-Tyr-OH) or in their content (1%, 3.5% and 8.4% mole of -Gly-Gly-OH side chains) were investigated with respect to their ability to induce antibody formation and mitogenic reaction in inbred strains of mice. The dependence on the antigen dose, on composition of the side chain and on the genetic background of the immunized organism was defined. It was demonstrated that the specificity of the antibody formed is predominantly directed against oligopeptide side chains, though some part of the antibody is also produced against hydroxypropyl chains. Neither the homopolymer nor the copolymers behave in the tissue culture as mitogens.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733215     DOI: 10.1016/0142-9612(84)90048-6

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  11 in total

1.  Biopolymer-based delivery systems for advanced imaging and skeletal tissue-specific therapeutics.

Authors:  Scott C Miller; Dong Wang; Pavla Kopecková; Jindrich Kopecek
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 2.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

Review 3.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

4.  Coiled-coil based drug-free macromolecular therapeutics: in vivo efficacy.

Authors:  Kuangshi Wu; Jiyuan Yang; Jihua Liu; Jindřich Kopeček
Journal:  J Control Release       Date:  2011-08-06       Impact factor: 9.776

5.  Thermoresponsive polymeric dexamethasone prodrug for arthritis pain.

Authors:  Gang Zhao; Rongguo Ren; Xin Wei; Zhenshan Jia; Ningrong Chen; Yuanyuan Sun; Zhifeng Zhao; Subodh M Lele; Haizhen A Zhong; Mary B Goldring; Steven R Goldring; Dong Wang
Journal:  J Control Release       Date:  2021-10-12       Impact factor: 9.776

Review 6.  Beyond oncology--application of HPMA copolymers in non-cancerous diseases.

Authors:  Xin-Ming Liu; Scott C Miller; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2009-11-10       Impact factor: 15.470

7.  HPMA copolymers: origins, early developments, present, and future.

Authors:  Jindrich Kopecek; Pavla Kopecková
Journal:  Adv Drug Deliv Rev       Date:  2009-11-14       Impact factor: 15.470

8.  Feasibility of using a bone-targeted, macromolecular delivery system coupled with prostaglandin E(1) to promote bone formation in aged, estrogen-deficient rats.

Authors:  S C Miller; H Pan; D Wang; B M Bowman; P Kopecková; J Kopecek
Journal:  Pharm Res       Date:  2008-08-29       Impact factor: 4.200

9.  Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.

Authors:  R Duncan; P Kopecková; J Strohalm; I C Hume; J B Lloyd; J Kopecek
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

Review 10.  The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides.

Authors:  Traian V Chirila; Piroska E Rakoczy; Kerryn L Garrett; Xia Lou; Ian J Constable
Journal:  Biomaterials       Date:  2002-01       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.